immuno therapy


Hallelujah! A Universal Flu Preventative and Therapy with Jeff Stein, Cidara

As another summer winds down, another flu season approaches. Yuuuk. When will we be able to stop living in fear of that crowded plane flight in winter months or waking up congested and wondering . . . dreading, “am I coming down with a cold?”

Yes, we get that annual flu vaccine shot, but each year we still get the bug. Until now, a real universal flu vaccine has eluded drug makers, and having the flu goes on being just part of life. But it doesn't have to be.

Today we talk with a company who is close to not a universal flu vaccine, but what they call a universal preventative.

Jeff Stein is the CEO of Cidara Therapetuics. Their technology is an immuno therapy which not only prevents all flus, but is a therapy as well in case you've already caught a bug.

Finally! Who isn’t rooting for this company?!

It’s a Gold Rush in Single Cell Genomics, Says Joachim Schultze, U of Bonn

The title says it all here. Herr Professor Schultze directs a major facility that he calls a single cell genomics platform. They have most of the single cell technologies available and partner with labs from all over the world on research.

Advances in single cell technologies are changing basic research and also delivering results for translational work in everything from immunology to obesity.

“Biology will never be the same again,” says Joachim.

Dr. Schultze is also heavily involved in epigenomics. He says that despite the ups and downs in this field, it still holds some exciting promise.

Talking to a leading genomicist in Germany, we ask for an outsider's view on our American approach to genomics.



New to Mendelspod?

We advance life science research, connecting people and ideas.
Register here to receive our newsletter.

or skip signup